Site Map
Privacy & Terms
Contact
Home
About
Senior Management
Board of Directors
Investment Highlights
Near-Term Strategy
Pipeline
Tumor Targeting
Cintredekin Besudotox
IPF
Neolipid Drug Delivery
LEP-ETU
LE-rafAON
LE-SN38
LE-DT
Intellectual Property
Investors
Press Releases
Events & Presentations
Corporate Governence
Financial Information
Stock Information
Investor FAQ
Contact Us
Careers
Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Senior Management
and Advisors
Board of Directors
Financial Information
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Ownership Profile
Investor FAQs
Contact Us
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Search Investor Relations
Financial Information
OTC:NEOL
$0.32
+ 0.07
Jul 30, 2010
3:45 PM ET
Here you will find a summary of NeoPharm, Inc.'s latest financial information.
Latest Earnings Release and 10-Q
Date Filed
Format
Size
Fourth Quarter Financial Results
N/A
Most Recent Annual Report
Date Filed
Format
Size
2009 Annual Report
628.6 KB
Latest Proxy Statement
Date Filed
Format
Size
2010 Proxy Statement
83.7 KB
= add file to Briefcase
Share Related Items
Market Cap.
(Mil)
$
Shares Out
(Mil)
Float
(Mil)
Share Related information provided by MorningStar, Inc.
Data as of Jul 31, 2010.
Mil=Millions